Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial.
Saved in:
| Title: | Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial. |
|---|---|
| Authors: | Chatzis, O.1 (AUTHOR), Blanchard-Rohner, G.1,2 (AUTHOR), Mondoulet, L.3 (AUTHOR), Pelletier, B.3 (AUTHOR), De Gea-Hominal, A.1 (AUTHOR), Roux, M.3 (AUTHOR), Huttner, A.1,4 (AUTHOR), Hervé, P.L.3 (AUTHOR), Rohr, M.2 (AUTHOR), Matthey, A.5 (AUTHOR), Gutknecht, G.5 (AUTHOR), Lemaître, B.6 (AUTHOR), Hayem, C.3 (AUTHOR), Pham, H.T.7 (AUTHOR), Wijagkanalan, W.7 (AUTHOR), Lambert, P.H.1 (AUTHOR), Benhamou, P.H.3 (AUTHOR), Siegrist, C.A.1,2 (AUTHOR) Claire-Anne.Siegrist@unige.ch |
| Source: | Clinical Microbiology & Infection. Jun2021, Vol. 27 Issue 6, p878-885. 8p. |
| Database: | Environment Complete |
| ISSN: | 1198743X |
|---|---|
| DOI: | 10.1016/j.cmi.2020.08.033 |
